Identifying new protein interactions to improve disease treatment
Exploring Understudied Proteins to Predict Novel Pathways and Associations to Disease
This study is looking at some lesser-known proteins to find new ways to develop better treatments for diseases, which could help patients get more effective options for their care.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10995987 on NIH RePORTER |
What this research studies
This research investigates the role of understudied proteins in disease pathways to enhance drug discovery. By utilizing high-throughput datasets, the project aims to uncover novel protein interactions that have been overlooked in traditional studies. The approach combines computational algorithms with biological data to predict new pathways that could lead to effective treatments for various diseases. Patients may benefit from this research as it seeks to identify new therapeutic targets that could improve treatment options.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diseases that have limited treatment options due to poorly understood biological pathways.
Not a fit: Patients with well-characterized diseases that already have effective treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new drug targets, potentially resulting in effective treatments for currently untreatable diseases.
How similar studies have performed: Previous research has shown promise in utilizing high-throughput data to uncover novel biological pathways, suggesting that this approach could yield significant advancements.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Nayar, Gowri — Stanford University
- Study coordinator: Nayar, Gowri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.